-
Adamis Pharmaceuticals Announces Closing of the Merger with DMK Pharmaceuticals
-
Adamis Pharmaceuticals (ADMP) Announces 1:70 Reverse Stock Split
-
Adamis Pharmaceuticals Announces Reverse Stock Split
-
Adamis Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
-
Adamis Pharmaceuticals Reports Full Year 2022 Financial Results and Provides Corporate Update
-
Adamis Pharmaceuticals (ADMP) Announces $3M Share Offering
-
Adamis Pharmaceuticals Announces $3.0 Million Registered Direct Offering
-
Adamis Pharmaceuticals (ADMP) will acquire DMK
-
Adamis Pharmaceuticals and DMK Pharmaceuticals Announce Agreement and Plan of Merger
-
Adamis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
-
Adamis Pharmaceuticals (ADMP) Announces Review of Strategic Alternatives
-
Adamis Announces Review of Strategic Alternatives
-
Unusual 11 Mid-Day Movers 8/29: (MCUR) (KONE) (STAF) Higher; (CZR) (BOSC) (CORE) Lower
-
Pre-Open Stock Movers 06/06: (VBLT) (YGE) (ONTY) Higher; (DNAI) (ADMP) (MRTX) Lower (more...)

